Uncategorised - European Medical Journal

The Journey to Drug Development

This week, Joubert Gama joins our EMJ Podcast host, Jonathan Sackier to discuss innovations in pharmaceutical sciences and drug developments.

Is There a Lack of Diverse Representation in Skin Ageing Prevention Information?

Skin ageing and prevention, according to a new study, may not be well-represented in females of colour. Read to find out more.

Addressing Skin Cancer in People of Colour

Addressing Skin Cancer in People of Colour

The aim of this study was to assess skin cancer awareness and to improve the knowledge of patients of colour, including encouraging the use of sunscreens as well as self-skin exams.

Physical Function and Cardiovascular Disease Events in Older Adults

The prognostic ability of traditional cardiovascular disease risk factors weakens as a function of age. Read to find out more…

Sex-Specific Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndrome

Researchers evaluated the sex-specific performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndrome…

Heated Tobacco Products and Cardiovascular Disease: A Narrative Review of Peer-Reviewed Publications

This article discussed cigarette smoking as a major risk factor for cardiovascular disease (CVD). Looking through the lens of toxic cigarette smoke constituents, the review described the oxidative stress and inflammatory responses induced following their entry into the bloodstream.

Frozen–Thawed Embryo Transfer and Risk of Childhood Cancer

Analysis of retrospective data on children born following frozen–thawed embryo transfer has shown a higher risk of childhood cancer…

Gestational Diabetes and Obesity with Excessive Weight Gain Linked To ADHD in Children?

New research had shown that children born to females with gestational diabetes and obesity were twice as likely to develop ADHD…

Pharmacovigilance past, present and future

Marc and Helena are joined by Pav Rishiraj, Director and Head of Pharmacovigilance, Ipsen, to shed light on this often-overlooked field.

Elevating pharma’s parental leave policies

With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?